Tag: Steve Jobs and neuroendocrine tumor treatment
Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients
May 20, 2011
The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread (metastasized) to …
READ MORE
Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients
May 20, 2011
The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread (metastasized) to …
READ MOREFortune Reports That Steve Jobs Sought Neuroendocrine Cancer Treatment in Switzerland
January 18, 2011
Fortune reported today, January 18, 2011, that Apple’s CEO Steve Jobs went to Basel, Switzerland in 2009 seeking treatment for neuroendocrine cancer. Read the story HERE.…
READ MORE
